TSPAN8 and neoplasm: In contrast to GSTM1, TSPAN8 was the only upregulated Black patient tumor specific gene (Fig 3C) that at high expression levels associated with an increase in the hazard ratio (1.81) and decrease overall survival by 7.5 months (Fig 5B).